Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group (Q70820714)
Jump to navigation
Jump to search
scientific article published on 01 September 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group |
scientific article published on 01 September 1995 |
Statements
Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group (English)
Atkinson K
Arthur C
Bradstock K
Dale B
Downs K
Gibson J
Golenia M
Ho J
Joshua D
1 September 1995